Folic acid supplementation attenuates hyperhomocysteinemia-induced preeclampsia-like symptoms in rats
查看参考文献27篇
|
文摘
|
Folic acid participates in the metabolism of homocysteine and lowers plasma homocysteine levels directly or indirectly.To establish a hyperhomocysteinemic pregnant rat model,2 mL of DL-homocysteine was administered daily by intraperitoneal injection at a dose of 200 mg/kg from day 10 to day 19 of gestation.Folic acid was administered by intragastric administration at a dose of 20 mg/kg during the period of preeclampsia induction.Results showed that systolic blood pressure,proteinuria/creatinine ratio,and plasma homocysteine levels in the hyperhomocys-teinemic pregnant rats increased significantly,and that body weight and brain weight of rat pups significantly decreased.Folic acid supplementation markedly reversed the above-mentioned abnormal changes of hyperhomocysteinemic pregnant rats and rat pups.These findings suggest that folic acid can alleviate the symptoms of hyperhomocysteinemia-induced preeclampsia in pregnant rats without influencing brain development of rat pups. |
|
来源
|
Neural Regeneration Research
,2012,7(25):1954-1959 【核心库】
|
|
DOI
|
10.3969/j.issn.1673-5374.2012.25.005
|
|
关键词
|
folic acid
;
preeclampsia
;
hyperhomocysteinemia
;
proteinuria
;
creatinine
;
preeclampsia-like symptom
;
pregnant rats
;
offspring
;
brain
;
nervous system
;
regeneration
;
neural regeneration
|
|
地址
|
1.
Department of Gynaecology and Obstetrics,the 202 Hospital of People’s Liberation Army, Liaoning, Shenyang, 110003
2.
Department of Emergency Medicine,General Hospital of Shenyang Military Region, Liaoning, Shenyang, 110016
3.
Department of Gynaecology and Obstetrics,the Second People’s Hospital of Tongliao, Inner Mongolia, Tongliao, 280000
|
|
语种
|
英文 |
|
ISSN
|
1673-5374 |
|
学科
|
妇产科学 |
|
基金
|
The Medical Science and Technology Foundation of Chinese PLA during Twelfth “Five-year” Development Period(General Program)
|
|
文献收藏号
|
CSCD:4648164
|
参考文献 共
27
共2页
|
|
1.
Valdiviezo C. Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk.
Clin Cardiol,2012,35(3):160-165
|
CSCD被引
1
次
|
|
|
|
|
2.
Tsai I H. Associations of the pre-pregnancy body mass index and gestational weight gain with pregnancy outcomes in Taiwanese women.
Asia Pac J Clin Nutr,2012,21(1):82-87
|
CSCD被引
4
次
|
|
|
|
|
3.
Roberts J M. Antioxidant therapy to prevent preeclampsia.
Semin Nephrol,2004,24(6):557-564
|
CSCD被引
1
次
|
|
|
|
|
4.
Molvarec A. Decreased proportion of peripheral blood vascular endothelial growth factor-expressing T and natural killer cells in preeclampsia.
Am J Obstet Gynecol,2010,203(6):567.e1-567.e8
|
CSCD被引
1
次
|
|
|
|
|
5.
Munjal C. Matrix metalloproteinase-9 in homocysteine-induced intestinal microvascular endothelial paracellular and transcellular permeability.
J Cell Biochem,2012,113(4):1159-1169
|
CSCD被引
5
次
|
|
|
|
|
6.
Kang R X. A natural squamosamide derivative FLZ inhibits homocysteine-induced rat brain microvascular endothelial cells dysfunction.
Biochem Biophys Res Commun,2012,417(4):1176-1181
|
CSCD被引
1
次
|
|
|
|
|
7.
Mccully K S. Chemical pathology of homocysteine. V. Thioretinamide, thioretinaco, and cystathionine synthase function in degenerative diseases.
Ann Clin Lab Sci,2011,41(4):301-314
|
CSCD被引
2
次
|
|
|
|
|
8.
Sen U. Homocysteine to hydrogen sulfide or hypertension.
Cell Biochem Biophys,2010,57(2/3):49-58
|
CSCD被引
19
次
|
|
|
|
|
9.
Khosrowbeygi A. Circulating levels of homocysteine in preeclamptic women.
Bangladesh Med Res Counc Bull,2011,37(3):106-109
|
CSCD被引
3
次
|
|
|
|
|
10.
Mislanova C. Placental markers of folate-related metabolism in preeclampsia.
Reproduction,2011,142(3):467-476
|
CSCD被引
1
次
|
|
|
|
|
11.
Hague W M. Homocysteine and pregnancy.
Best Pract Res Clin Obstet Gynaecol,2003,17(3):459-469
|
CSCD被引
2
次
|
|
|
|
|
12.
Davisson R L. Discovery of a spontaneous genetic mouse model of preeclampsia.
Hypertension,2002,39(2 Pt 2):337-342
|
CSCD被引
7
次
|
|
|
|
|
13.
Cross J C. The genetics of pre-eclampsia: a feto-placental or maternal problem?.
Clin Genet,2003,64(2):96-103
|
CSCD被引
6
次
|
|
|
|
|
14.
Granger J P. Reduced uterine perfusion pressure (RUPP) model for studying cardiovascular-renal dysfunction in response to placental ischemia.
Methods Mol Med,2006,122:383-392
|
CSCD被引
6
次
|
|
|
|
|
15.
Mutter W P. Molecular mechanisms of preeclampsia.
Microvasc Res,2008,75(1):1-8
|
CSCD被引
14
次
|
|
|
|
|
16.
Bodnar L M. Periconceptional multivitamin use reduces the risk of preeclampsia.
Am J Epidemiol,2006,164(5):470-477
|
CSCD被引
5
次
|
|
|
|
|
17.
Fekete K. Perinatal folate supply: relevance in health outcome parameters.
Matern Child Nutr,2010,6(Suppl 2):23-38
|
CSCD被引
2
次
|
|
|
|
|
18.
Olthof M R. Effect of folic acid and betaine supplementation on flow-mediated dilation: a randomized, controlled study in healthy volunteers.
PLoS Clin Trials,2006,1(2):e10
|
CSCD被引
1
次
|
|
|
|
|
19.
Powers R W. Moderate hyperhomocysteinemia decreases endothelial-dependent vasorelaxation in pregnant but not nonpregnant mice.
Hypertension,2004,44(3):327-333
|
CSCD被引
1
次
|
|
|
|
|
20.
Stanger O. Enzymatic and non-enzymatic antioxidative effects of folic acid and its reduced derivates.
Subcell Biochem,2012,56:131-161
|
CSCD被引
1
次
|
|
|
|
|
了解气象卫星更多信息，请访问